Article Details

CDSCO Panel Approves Pfizer Protocol Amendment proposal to study anti-cancer drug Elranatamab

Retrieved on: 2024-11-04 19:33:23

Tags for this article:

Click the tags to see associated articles and topics

CDSCO Panel Approves Pfizer Protocol Amendment proposal to study anti-cancer drug Elranatamab. View article details on hiswai:

Excerpt

It is a humanized immunoglobulin 2-alanine kappa antibody derived from two monoclonal antibodies (mAbs), an anti-BCMA mAb and an anti-CD3 mAb ...

Article found on: medicaldialogues.in

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up